Identification of lesional attributes of dysmenorrhea severity and the serum antimüllerian hormone levels in women with ovarian endometriomas

Nie J, Jichan Nie, Chenyan Zhao, Antonio Simone Laganà, Liu X, Xishi Liu, Sun-Wei Guo, Sun‐Wei Guo
Fertility and sterility · 2022 · vol. 118(1) , pp. 191–202 · doi:10.1016/j.fertnstert.2022.04.016 · PMID:35641324 · W4281781595
article OA: closed CC0 ⤵ 48 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This study identified specific lesional attributes of ovarian endometriomas that correlate with dysmenorrhea severity and serum anti-Müllerian hormone levels.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To investigate whether lesional immunostaining of putative biomarkers of recurrence and the extent of lesional and cortical fibroses are correlated with the severity of dysmenorrhea and serum antimüllerian hormone (AMH) levels in women with ovarian endometriomas (OEs). DESIGN: Retrospective cohort study. SETTING: Academic hospital. PATIENT(S): A total of 313 women with histologically confirmed OEs were recruited. Their demographic and clinical information and data on their preoperative AMH levels were collected. Additionally, samples of their lesional tissues and ovarian cortex tissues adjacent to the OE lesions were procured for histologic and immunohistochemistry analyses. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): All OE tissue samples were stained for phosphorylated nuclear factor κB p65 subunit, progesterone receptor isoform B, Slit2, and α-smooth muscle actin. In addition, the extent of lesional and cortical fibroses was quantitated by Masson trichrome staining. We evaluated the relationship between the lesion size; laterality; extent of lesional and cortical fibroses, along with the putative markers of recurrence; and severity of dysmenorrhea and preoperative serum AMH levels in patients with OE. RESULT(S): We found that the extent of lesional fibrosis was positively correlated with the severity of dysmenorrhea but had no impact on the AMH levels. On the other hand, the extent of cortical fibrosis, along with age, was negatively correlated with the AMH levels. CONCLUSION(S): The correlation between lesional fibrosis and the severity of dysmenorrhea and between cortical fibrosis and the AMH levels would call an early intervention once OE is diagnosed or suspected to prevent further pain and diminished ovarian reserve.

My notes (saved in your browser only)

Condition tags

dysmenorrheaendometriosis

MeSH descriptors

Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Anti-Mullerian Hormone Endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (71)

Cited by (49)

Source provenance

europepmc
last seen: 2026-07-27T06:15:28.040536+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-06-27T06:13:29.261889+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK